Correlation of Thromboelastography with Apparent Rivaroxaban Concentration

Editor’s Perspective What We Already Know about This Topic What This Article Tells Us That Is New Background Concern remains over reliable point-of-care testing to guide reversal of rivaroxaban, a commonly used factor Xa inhibitor, in high-acuity settings. Thromboelastography (TEG), a point-of-care viscoelastic assay, may have the ability to detect the anticoagulant effect of rivaroxaban. The authors ascertained the association of apparent...